Telemedicine Education for Caregivers and Asthma Control in Children
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-16
SponsorCan Tho University of Medicine and Pharmacy
About this trial
Asthma control in pediatric patients remains a critical issue for healthcare providers. Telemedicine has emerged as an effective solution for overcoming distance barriers in healthcare delivery. This study aims to utilize telemedicine-based education for caregivers to improve asthma control in children with uncontrolled asthma. By providing remote guidance and support, the study seeks to enhance caregivers' knowledge and management practices, ultimately leading to better asthma outcomes for pediatric patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pediatric asthma patients diagnosed according to the GINA guidelines, classified as having uncontrolled asthma, are managed and followed up for at least 1 month at the pediatric asthma unit of the outpatient department.
Disqualifiers
Pediatric patients who do not cooperate or are unable to complete the Childhood Asthma Control Test questionnaire.
Caregivers who cannot complete the questionnaires related to the assessment of asthma control and associated factors.
Pediatric patients who have siblings participating in the study.
Patients currently participating in another clinical study (excluding non-interventional studies or registries).
Trial design
Design model
Parallel
Treatments tested in this trial
Telemedicine-Based Education
Other interventionIntervention through telemedicine
Standard Care (in control arm)
Other interventionSham comparator through telemedicine
Treatment groups
64 Participants
are divided into 2 treatment groupsGroup A: Standard careSham comparator 1 intervention
Group B: TelemedicineExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
The improvement of asthma control
The patients will be evaluated for asthma control using the Childhood Asthma Control Test (C-ACT) for children aged 4-11 or Asthma Control Test (ACT) for children aged 12 and older. This evaluation will also be compared to the baseline to determine whether there is improvement after the intervention period.
Time frame
At second follow-up visit (ranging from 4 to 24 weeks after enrollment)Secondary outcomes
1
The improvement of caregiver's knowledge regarding asthma control
The caregiver's knowledge regarding asthma will be assessed using a validated questionnaire. This evaluation will also be compared to the baseline to determine whether there is improvement after the intervention period.
Time frame
At second follow-up visit (ranging from 4 to 24 weeks after enrollment)2
The improvement of caregiver's attitudes toward asthma management
Caregiver's attitudes toward asthma management will be assessed using a set of questions designed to evaluate their perspectives on key aspects of asthma care, including the importance of regular doctor visits, adherence to controller medications, following prescription instructions, proper cleaning of inhaler devices, and mouth rinsing after inhaler use. The evaluation will be compared to baseline data to determine whether there is an improvement in caregivers' attitudes after the intervention period.
Time frame
At second follow-up visit (ranging from 4 to 24 weeks after enrollment)3
The improvement of proper inhaler technique usage
The patients will be evaluated on their proper inhaler use technique using a consistent checklist. This evaluation will be compared to the baseline to determine whether there is any improvement after the intervention period.
Time frame
At second follow-up visit (ranging from 4 to 24 weeks after enrollment)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov